ATP13A3 anticorps (N-Term)

N° du produit ABIN5535915

Détail du produit anti-ATP13A3 anticorps

Antigène: ATP13A3 (ATPase Type 13A3 (ATP13A3))

Épitope: AA 101-129, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ATP13A3 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ATP13A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 101-129 amino acids from the N-terminal region of human ATP13A3.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:50~100

For FACS starting dilution is: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur ATP13A3

Antigène: ATP13A3 (ATPase Type 13A3 (ATP13A3))

Autre désignation: ATP13A3 (ATP13A3 Produits)

Synonymes: anticorps AFURS1, anticorps AU022875, anticorps Gm1745, anticorps Gm541, anticorps Gm542, anticorps ATPase 13A3, anticorps probable cation-transporting ATPase 13A3, anticorps ATPase type 13A3, anticorps ATP13A3, anticorps LOC577790, anticorps LOC100163879, anticorps LOC100202365, anticorps atp13a3, anticorps LOC100561002, anticorps Atp13a3

Poids moléculaire: 138 kDa

ID gène: 79572

UniProt: Q9H7F0

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2